CPX-351 daunorubicin-cytarabine liposome: a novel formulation to treat patients with newly diagnosed secondary acute myeloid leukemia
Author:
Publisher
Edizioni Minerva Medica
Subject
General Medicine
Link
https://www.minervamedica.it/pdf.php?cod=R10Y2020N05A0455
Reference38 articles.
1. Acute myeloid leukaemia
2. Current and emerging therapies for acute myeloid leukemia
3. Incidence, survival and prevalence of myeloid malignancies in Europe
4. The incidence of secondary leukemias;Leone G;Haematologica,1999
5. The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: a study of 760 patients with a minimal follow-up time of 6 years
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An insight of various vesicular systems, erythrosomes, and exosomes to control metastasis and cancer;Advances in Cancer Biology - Metastasis;2023-07
2. Smart and Generalizable Cytarabine Derivative-Triggered Nanoparticles for Synergistic Therapy of Relapsed/Refractory Acute Myeloid Leukemia;ACS Applied Materials & Interfaces;2023-05-30
3. Liposome-Encapsulated Melphalan Exhibits Potent Antimyeloma Activity and Reduced Toxicity;ACS Omega;2022-12-29
4. Myelodysplastic Syndromes;Holland‐Frei Cancer Medicine;2022-10-21
5. Nanomedicines for Overcoming Cancer Drug Resistance;Pharmaceutics;2022-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3